Not applicableNot Yet RecruitingNCT05371392What this trial is testingPolymorphism of ITGA4 Gene in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Sohag University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872What this trial is testingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 547
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)Looking for participantsNCT06547528What this trial is testingA Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLWho this might be right forRelapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Ono Pharmaceutical Co., Ltd. 108
Not applicableUnknownNCT03971565What this trial is testingEvaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Assistance Publique Hopitaux De Marseille 47
Testing effectiveness (Phase 2)Study completedNCT01532700What this trial is testingAn Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL) University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT01373229What this trial is testingLenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-Cell David Rizzieri, MD 21
Not applicableStudy completedNCT00038675What this trial is testingTherapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateWho this might be right forChronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Study completedNCT01246557What this trial is testingStudy Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to TreatmentWho this might be right forChronic Lymphatic Leukemia Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00054431What this trial is testingImatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+2 more National Cancer Institute (NCI) 80
Early research (Phase 1)Looking for participantsNCT05367700What this trial is testingHS-10382 in Patients With Chronic Myeloid Leukemia.Who this might be right forCML, Chronic PhaseCML, Accelerated Phase Jiangsu Hansoh Pharmaceutical Co., Ltd. 108
Testing effectiveness (Phase 2)Looking for participantsNCT04996875What this trial is testing(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisWho this might be right forAdvanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more Cogent Biosciences, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT02533401What this trial is testingRituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 34
Testing effectiveness (Phase 2)Looking for participantsNCT05147467What this trial is testingStudy of APG-2575 in Patients With Relapsed/Refractory CLL/SLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Ascentage Pharma Group Inc. 75
Not applicableLooking for participantsNCT06684964What this trial is testingRWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)Who this might be right forChronic Myelogenous Leukemia in Chronic Phase Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Not Yet RecruitingNCT07254793What this trial is testingProphylactic and Therapeutic DLI-X for Leukemia Relapse After HCTWho this might be right forAcute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more University of Arizona 94
Testing effectiveness (Phase 2)WithdrawnNCT00845104What this trial is testingFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Not applicableUnknownNCT04150471What this trial is testingAssess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia PatientsWho this might be right forChronic Myelocytic Leukemia Seoul St. Mary's Hospital 79
Testing effectiveness (Phase 2)Study completedNCT02968563What this trial is testingStudy to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Gilead Sciences 35